Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeri Kim

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Expert Review of Anticancer Therapy|October 15, 2010
Chemoprevention of prostate cancer: breakthroughs and controversiesJeri Kim
Cancer Prevention Research (Philadelphia, Pa.)|June 4, 2009
Molecular profiles of finasteride effects on prostate carcinogenesisJin Li, Jeri Kim
JAMA|December 29, 2011
Prostate cancer screening--time to abandon one-size-fits-all approach?Jeri Kim, John W Davis
The New England Journal of Medicine|December 16, 2011
5α-Reductase inhibitors for prostate-cancer preventionJeri Kim, Christopher I Amos, Christopher Logothetis
BJU International|June 17, 2017
Active surveillance in prostate cancer: new efforts, new voices, new hopeSpyridon P Basourakos, Karen Hoffman, Jeri Kim
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Informative clinical investigation: a demanding taskmasterEleni Efstathiou, Jeri Kim, Christopher J Logothetis
Lung Cancer (Amsterdam, Netherlands)|June 12, 2002
Non-small cell lung cancer clinical trials with trastuzumab: their foundation and preliminary resultsRalph G Zinner, Jeri Kim, Roy S Herbst
Future Oncology (London, England)|May 28, 2021
KEYNOTE-641: a Phase III study of pembrolizumab plus enzalutamide for metastatic castration-resistant prostate cancerJulie N Graff, Li Wen Liang, Jeri Kim, et al.
Clinical Genitourinary Cancer|October 23, 2012
Cixutumumab-associated pancolitis in a patient with prostate cancerMehmet Asim Bilen, Jeri Kim, Huamin Wang, et al.
Carcinogenesis|September 1, 2017
Methylation of subtelomeric repeat D4Z4 in peripheral blood leukocytes is associated with biochemical recurrence in localized prostate cancer patientsYuyan Han, Junfeng Xu, Jeri Kim, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Expert Review of Anticancer Therapy|October 15, 2010
Chemoprevention of prostate cancer: breakthroughs and controversiesJeri Kim
Cancer Prevention Research (Philadelphia, Pa.)|June 4, 2009
Molecular profiles of finasteride effects on prostate carcinogenesisJin Li, Jeri Kim
JAMA|December 29, 2011
Prostate cancer screening--time to abandon one-size-fits-all approach?Jeri Kim, John W Davis
The New England Journal of Medicine|December 16, 2011
5α-Reductase inhibitors for prostate-cancer preventionJeri Kim, Christopher I Amos, Christopher Logothetis
BJU International|June 17, 2017
Active surveillance in prostate cancer: new efforts, new voices, new hopeSpyridon P Basourakos, Karen Hoffman, Jeri Kim
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Informative clinical investigation: a demanding taskmasterEleni Efstathiou, Jeri Kim, Christopher J Logothetis
Lung Cancer (Amsterdam, Netherlands)|June 12, 2002
Non-small cell lung cancer clinical trials with trastuzumab: their foundation and preliminary resultsRalph G Zinner, Jeri Kim, Roy S Herbst
Future Oncology (London, England)|May 28, 2021
KEYNOTE-641: a Phase III study of pembrolizumab plus enzalutamide for metastatic castration-resistant prostate cancerJulie N Graff, Li Wen Liang, Jeri Kim, et al.
Clinical Genitourinary Cancer|October 23, 2012
Cixutumumab-associated pancolitis in a patient with prostate cancerMehmet Asim Bilen, Jeri Kim, Huamin Wang, et al.
Carcinogenesis|September 1, 2017
Methylation of subtelomeric repeat D4Z4 in peripheral blood leukocytes is associated with biochemical recurrence in localized prostate cancer patientsYuyan Han, Junfeng Xu, Jeri Kim, et al.
Pageof 11